Cartesian Therapeutics
RNAC
#6874
Rank
NZ$0.77 B
Marketcap
$30.66
Share price
-5.09%
Change (1 day)
-47.13%
Change (1 year)

Earnings for Cartesian Therapeutics (RNAC)

Earnings in 2024 (TTM): -NZ$0.4 Billion

According to Cartesian Therapeutics's latest financial reports the company's current earnings are NZ$54.1 Million. In 2023 the company made an earning of -NZ$0.41 Billion a decrease over its 2022 earnings that were of NZ$64.71 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Cartesian Therapeutics from 2015 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -NZ$0.4 Billion-1.84%
2023 -NZ$0.41 Billion-724%
2022 NZ$64.71 M-649.67%
2021 -NZ$11.78 Million-89.78%
2020 -NZ$0.12 Billion25.06%
2019 -NZ$92.16 Million-15.68%
2018 -NZ$0.11 Billion-0.43%
2017 -NZ$0.11 Billion83.41%
2016 -NZ$59.85 Million44.3%
2015 -NZ$41.48 Million